Dr. Onyinyechukwu Igbokwe, MD

Dr. Igbokwe practices at Presbyterian Española Hospital in Espanola, New Mexico, part of Presbyterian Healthcare Services.

Dr. Igbokwe's NPI, 1811550585, was assigned on April 18, 2019. Dr. Igbokwe holds New Mexico license MD2022-0429.

Dr. Igbokwe's primary practice is Presbyterian Española Hospital, at 1010 Spruce Street, Espanola, NM 87532 in Rio Arriba County. The practice phone is (505) 753-1502.

Dr. Igbokwe's primary practice is Presbyterian Española Hospital in Espanola, New Mexico, part of Presbyterian Healthcare Services. Dr. Igbokwe is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Igbokwe to 3 more hospitals and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Igbokwe practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Igbokwe's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Igbokwe is licensed in New Mexico.

CMS data shows 217 Medicare services from Dr. Igbokwe across 3 procedure codes in 2024, all of them office visits, for 107 Medicare patients. Medicare paid $14,362 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Dr. Igbokwe in 2024. The largest group is 65 to 74, with 48 patients. 62% of them have high cholesterol, and 55% have high blood pressure. 29% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Igbokwe's median patient age at 58, with 62% women.

In 2024, Dr. Igbokwe wrote 2,537 Medicare Part D claims for 216 patients. 88% of them were for generic drugs. CMS names the drug for 2,074 of them, across 60 drugs with 11 or more claims each, at $231,851 in total drug cost. In 2023, CMS named 756 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Igbokwe for performance year 2024, reported as part of a group. Dr. Igbokwe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Igbokwe as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 5 general payments to Dr. Igbokwe from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $60.